anal neoplasm: A benign or malignant neoplasm that affects the anal canal or anal margin. Representative examples of benign neoplasms include squamous papilloma and papillary hidradenoma. Representative examples of malignant neoplasms include carcinoma, lymphoma, and melanoma.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1052 |
4. Check minimum number of eventsNone |
1052 |
5. Include endpointsNone |
1052 |
6. Filter based on genotype QC (FinnGen only) |
1016 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D12
- Name in latin
- Neoplasma benignum ani
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Anus and anal canal
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Rectum, anus and anal canal
- Benign neoplasm of colon, rectum, anus and anal canal
- Benign neoplasms
- Neoplasms
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 6775 | 3595 | 3140 |
| Only index persons | 6211 | 3389 | 2822 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.10 | 0.10 | 0.09 |
| Only index persons | 0.12 | 0.12 | 0.11 |
| Median age at first event (years) | |||
| Whole population | 65.19 | 64.63 | 65.80 |
| Only index persons | 64.31 | 63.88 | 64.84 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1016 | 530 | 486 |
| Unadjusted period prevalence (%) | 0.20 | 0.19 | 0.22 |
| Median age at first event (years) | 63.18 | 60.50 | 66.11 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1052
- Matched controls
- 10516
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D12.9
ICD-10 Finland
Benign neoplasm: Anus and anal canal
+∞
307.7
1051
*
JHA20
NOMESCO Finland
Excision of lesion of anal canal or perianal tissue
58.1
300.7
171
35
UJF32
NOMESCO Finland
Coloscopy
8.5
264.5
700
1992
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
13.2
223.0
235
224
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
8.1
185.6
303
503
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
8.2
143.4
214
316
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
7.3
123.5
204
335
K62.0
ICD-10 Finland
Anal polyp
31.0
113.4
75
26
UJH02
NOMESCO Finland
Anoscopy
8.0
100.6
148
212
UJG02
NOMESCO Finland
Proctoscopy
10.7
84.9
96
98
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
5.4
75.3
166
354
JGA05
NOMESCO Finland
Endoscopic polypectomy in rectum
24.3
58.5
42
18
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
4.3
56.7
165
437
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
7.5
54.0
80
114
JHB00
NOMESCO Finland
Hemorrhoidectomy
6.7
52.9
88
142
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
6.1
51.9
95
169
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
5.1
48.7
109
233
JHA00
NOMESCO Finland
Anal or perianal incision
10.7
45.1
50
49
I84.9
ICD-10 Finland
Unspecified hemorrhoids without complication
4.7
43.5
106
243
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
7.7
43.2
62
85
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.6
40.3
304
1412
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.4
39.3
413
2231
UJF30
NOMESCO Finland
Ileoscopy through colon
3.2
38.7
172
599
C05AA08
ATC
fluocortolone; rectal, topical
2.9
38.2
216
863
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
5.7
37.4
72
134
A06AC01
ATC
ispaghula (psylla seeds); oral
2.3
35.9
376
2013
D12.7
ICD-10 Finland
Benign neoplasm: Rectosigmoid junction
8.2
30.4
41
52
JGA73
NOMESCO Finland
Transanal excision of lesion of rectum
31.9
28.3
37
12
K60.1
ICD-10 Finland
Chronic anal fissure
5.8
28.1
52
93
D12
ICD-10 Finland
Benign neoplasm of colon, rectum, anus and anal canal
27.8
25.9
35
13
D12.4
ICD-10 Finland
Benign neoplasm: Descending colon
6.0
25.6
46
80
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
3.4
25.0
94
293
ZXE00
NOMESCO Finland
One hour or less
2.0
24.9
461
2976
K62.1
ICD-10 Finland
Rectal polyp
8.8
24.6
31
36
I84.5
ICD-10 Finland
External hemorrhoids without complication
4.5
23.9
60
140
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
21.1
310
1826
D37.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Rectum
7.6
20.4
29
39
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
4.5
20.1
50
116
JHA10
NOMESCO Finland
Biopsy of anal canal
58.7
20.0
23
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
19.9
389
2510
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
18.6
19.2
29
16
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
4.8
18.8
43
93
D37.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Colon
5.5
18.6
36
67
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
18.2
265
1546
K60.3
ICD-10 Finland
Anal fistula
5.8
18.1
33
58
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.4
16.9
130
591
Z2221
NOMESCO Finland
Medical doctor
1.8
16.0
306
1938
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.8
15.9
302
1908
N02AX02
ATC
tramadol; systemic, rectal
1.7
15.8
481
3474
JFG10
NOMESCO Finland
Closure of loop colostomy without resection
7.3
15.7
23
32
K64.2
ICD-10 Finland
Third degree haemorrhoids
6.3
15.5
26
42
A02BC05
ATC
esomeprazole; systemic
1.7
15.3
441
3129
WX402
NOMESCO Finland
General anaesthesia
1.9
15.0
221
1286
J01DB01
ATC
cefalexin; oral
1.9
15.0
854
7287
A02BC03
ATC
lansoprazole; oral
1.7
14.7
334
2213
D04
ICPC
Rectal/anal pain
5.2
14.6
30
59
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
5.2
14.6
30
59
A02BC02
ATC
pantoprazole; systemic
1.7
14.6
723
5891
A06AC51
ATC
ispaghula, combinations; oral
2.9
14.5
72
264
N02BE01
ATC
paracetamol; systemic, rectal
2.2
14.3
940
8330
K60.2
ICD-10 Finland
Anal fissure, unspecified
5.2
14.2
29
57
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.9
14.1
215
1263
N03AX16
ATC
[U] pregabalin
1.8
13.9
264
1659
I84
ICD-10 Finland
Hemorrhoids
3.4
13.1
47
142
P01AB01
ATC
metronidazole; oral, rectal
1.6
13.1
411
2950
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
12.8
412
2971
I84.1
ICD-10 Finland
Internal hemorrhoids with other complications
3.7
12.4
39
108
I84.4
ICD-10 Finland
External hemorrhoids with other complications
5.2
12.2
25
49
ZXE20
NOMESCO Finland
More than three and less than five hours
1.9
12.2
162
906
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.7
12.0
67
261
TPH07
NOMESCO Finland
Cathetrisation of artery
2.0
12.0
141
756
JHW96
NOMESCO Finland
Other operation on anus or perianal tissue
14.9
11.8
19
13
K61.0
ICD-10 Finland
Anal abscess
5.0
11.7
25
51
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
11.5
242
1555
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
11.4
214
1332
UJF92
NOMESCO Finland
Capsular endoscopy
4.0
11.3
32
82
WX110
NOMESCO Finland
Infiltration anesthesia
1.6
10.9
685
5694
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.8
10.9
181
1086
Z71.8
ICD-10 Finland
Other specified counselling
1.6
10.8
298
2051
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
3.0
10.7
47
161
K64.4
ICD-10 Finland
Residual haemorrhoidal skin tags
13.1
10.7
18
14
C21.1
ICD-10 Finland
Malignant neoplasm: Anal canal
60.6
10.6
12
*
JN3AD
NOMESCO Finland
Abdominal CT examination
2.0
10.6
129
700
WX002
NOMESCO Finland
Sedation and analgesia
1.7
10.5
219
1401
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
10.3
309
2165
K59.0
ICD-10 Finland
Constipation
2.3
10.2
75
334
R4110
NOMESCO Finland
Physiotherapy
1.6
10.1
290
2010
Z3231
NOMESCO Finland
Registered nurse
1.6
10.1
287
1986
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.7
9.9
54
209
JF2BD
NOMESCO Finland
Extensive colon CT
8.2
9.9
21
26
K92.1
ICD-10 Finland
Melaena
2.3
9.6
72
323
A02BC01
ATC
omeprazole; systemic
1.6
9.5
293
2062
D01
ICPC
Abdominal pain/cramps general
1.9
9.5
116
629
WZC00
NOMESCO Finland
Treatment plan or consultation
1.5
9.5
342
2494
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.2
9.3
81
387
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.7
9.3
184
1157
JG1CG
NOMESCO Finland
Extensive MRI of rectum
9.6
9.3
18
19
K64.9
ICD-10 Finland
Haemorrhoids, unspecified
3.0
9.2
41
142
K96
ICPC
Haemorrhoids
3.1
8.9
36
118
JGA75
NOMESCO Finland
Endoscopic microsurgical excision of lesion of rectum
50.4
8.7
10
*
JFF23
NOMESCO Finland
Transversostomy
4.3
8.7
22
52
K57
ICD-10 Finland
Diverticular disease of intestine
3.6
8.6
28
80
JFA45
NOMESCO Finland
Endoscopic contact coagulation in colon
10.1
8.5
16
16
JGA96
NOMESCO Finland
Other proctotomy or local operation on rectum
27.7
8.5
11
*
N06AB04
ATC
citalopram; systemic
1.6
8.4
209
1392
K60.0
ICD-10 Finland
Acute anal fissure
4.9
8.4
18
37
Z3226
NOMESCO Finland
Physiotherapist
1.6
8.3
190
1241
WX702
NOMESCO Finland
Supraglottic ventilation device
2.3
8.3
62
279
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.0
8.2
93
492
R35
ICD-10 Finland
Polyuria
2.1
8.2
80
401
A07EA02
ATC
hydrocortisone; rectal
3.4
8.1
28
83
S18
ICPC
Laceration/cut
1.5
8.0
465
3707
R60.0
ICD-10 Finland
Localized oedema
1.7
7.8
136
823
K62.3
ICD-10 Finland
Rectal prolapse
4.1
7.8
21
52
N05CF01
ATC
zopiclone; oral
1.5
7.8
338
2541
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.0
7.8
88
464
WX892
NOMESCO Finland
Monitored bed care
2.0
7.8
87
458
Z01.2
ICD-10 Finland
Dental examination
1.5
7.8
393
3047
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
3.2
7.7
30
96
JHC60
NOMESCO Finland
Transanal submucous or intersphincteric injection
45.3
7.7
9
*
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
1.6
7.7
185
1220
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.4
7.7
53
230
JN4BD
NOMESCO Finland
Extensive body CT
1.8
7.6
119
698
A03CA02
ATC
clidinium and psycholeptics; oral
2.1
7.6
69
336
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.6
7.6
42
164
H02AB06
ATC
prednisolone; systemic
1.4
7.6
478
3857
Z93.3
ICD-10 Finland
Colostomy status
6.2
7.6
19
31
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
7.5
483
3907
UJD02
NOMESCO Finland
Gastroscopy
2.3
7.5
56
251
A02BA04
ATC
nizatidine; systemic
1.9
7.4
89
480
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.2
7.4
58
266
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
7.3
366
2822
UJF34
NOMESCO Finland
Left colonoscopy
6.9
7.3
17
25
K64.1
ICD-10 Finland
Second degree haemorrhoids
3.3
7.3
27
84
L01
ICPC
Neck symptom/complaint
1.7
7.2
144
905
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.8
7.2
103
588
K21
ICD-10 Finland
Gastro-oesophageal reflux disease
2.2
7.1
57
264
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.8
7.0
103
593
R01AD08
ATC
fluticasone; nasal
1.5
7.0
252
1819
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.8
7.0
107
624
G50.1
ICD-10 Finland
Atypical facial pain
3.3
6.9
25
77
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
6.8
434
3487
J02AC02
ATC
itraconazole; systemic
1.6
6.8
164
1081
A07EC02
ATC
mesalazine; oral, rectal
2.2
6.8
55
256
D64.9
ICD-10 Finland
Anaemia, unspecified
1.7
6.8
121
737
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
3.1
6.8
27
88
N06AX11
ATC
mirtazapine; oral
1.4
6.7
326
2492
M79.6
ICD-10 Finland
Pain in limb
1.4
6.7
402
3193
D16
ICPC
Rectal bleeding
2.9
6.7
30
105
M79.7
ICD-10 Finland
Fibromyalgia
2.6
6.7
37
145
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
2.5
6.7
39
157
C10AC01
ATC
colestyramine; oral
2.8
6.6
33
122
N06AX21
ATC
duloxetine; oral
1.7
6.6
112
674
JHB96
NOMESCO Finland
Other procedure for haemorrhoids or prolapse of mucosa
10.1
6.5
12
12
K62.9
ICD-10 Finland
Disease of anus and rectum, unspecified
7.4
6.4
14
19
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.5
6.4
202
1416
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.6
6.4
182
1247
ZXA05
NOMESCO Finland
Left side
1.5
6.4
260
1920
H53.1
ICD-10 Finland
Subjective visual disturbances
2.0
6.3
65
332
N05BA04
ATC
oxazepam; oral
1.5
6.3
251
1844
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
6.3
355
2782
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
6.3
160
1068
D01.2
ICD-10 Finland
Carcinoma in situ: Rectum
+∞
6.3
6
*
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.9
6.2
84
471
C21.0
ICD-10 Finland
Malignant neoplasm: Anus, unspecified
26.8
6.2
8
*
UKC02
NOMESCO Finland
Cystoscopy
1.6
6.2
174
1188
K57.9
ICD-10 Finland
Diverticular disease of intestine, part unspecified, without perforation or abscess
2.7
6.2
32
121
K62.8
ICD-10 Finland
Other specified diseases of anus and rectum
5.8
6.2
16
28
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.7
6.2
129
821
R06.5
ICD-10 Finland
Mouth breathing
1.9
6.1
80
444
JFA55
NOMESCO Finland
Other endoscopic procedure using diathermy or heat in colon
7.7
6.1
13
17
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
6.1
474
3919
K64.0
ICD-10 Finland
First degree haemorrhoids
3.1
6.1
24
78
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.8
6.0
89
513
R03AC02
ATC
salbutamol; inhalant
1.4
6.0
517
4338
R32
ICD-10 Finland
Unspecified urinary incontinence
2.7
6.0
32
123
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
544
3903
1.81
19.63
5.5
4.7
35.02
35.10
g/l
0.13
507
3609
182
979
2.04
15.51
4.3
4.0
3.72
24.65
ug/l
1.77
156
815
770
6372
1.78
14.85
4.8
4.1
13.07
13.23
mm/h
0.10
707
5844
484
3585
1.65
13.81
3.4
2.8
158.58
136.32
ug/l
0.32
451
3259
168
928
1.96
13.16
2.7
2.1
125.48
140.35
ug/g
0.27
124
736
619
4911
1.63
13.14
8.7
8.9
4.33
4.18
e9/l
0.64
534
4300
338
2327
1.67
12.56
2.6
2.2
3.04
3.13
mg/l
0.27
290
1960
556
4338
1.60
12.31
18.8
17.4
1.26
1.30
inr
0.46
153
1237
526
4073
1.58
11.86
6.2
5.8
26.93
26.81
%
0.09
495
3819
638
5178
1.59
11.66
5.2
4.7
6.78
6.75
mmol/l
0.10
605
4867
517
4004
1.57
11.54
5.8
5.6
57.83
58.05
%
0.14
485
3759
490
3749
1.57
11.53
2.2
2.1
97.73
94.15
pmol/l
0.84
262
1945
463
3507
1.57
11.32
2.3
2.2
79.85
78.31
nmol/l
0.58
407
3082
783
6706
1.65
11.18
9.4
7.5
78.48
78.94
u/l
0.09
739
6284
201
1235
1.77
11.15
2.6
2.5
21.69
22.42
%
0.28
172
1057
380
2762
1.59
11.03
3.2
2.5
59.34
89.17
u/l
0.51
343
2551
314
2202
1.61
10.50
4.5
3.8
88.61
87.77
%
0.23
308
2148
220
1415
1.70
10.31
2.5
2.5
12.02
12.68
umol/l
0.69
207
1318
513
4052
1.52
9.93
3.0
2.6
—
—
—
0
0
204
1305
1.70
9.70
2.6
2.5
2.29
2.30
g/l
0.08
188
1211
301
2134
1.57
9.45
3.0
2.4
—
—
—
0
0
549
4448
1.49
9.09
7.3
6.6
1.21
1.21
mmol/l
0.07
461
3754
512
4093
1.49
9.04
6.4
5.8
1.21
1.21
mmol/l
0.19
471
3712
135
787
1.82
8.83
2.4
2.3
35.04
36.58
u/l
0.11
112
669
922
8403
1.78
8.73
20.8
15.7
23.06
25.34
mg/l
1.28
796
6781
410
3155
1.49
8.63
4.3
3.8
105.81
129.18
e6/l
0.23
296
2299
950
8747
1.88
8.55
23.5
18.5
3.97
3.99
mmol/l
1.56
927
8503
948
8733
1.86
8.37
23.0
18.4
139.58
139.63
mmol/l
0.27
927
8501
118
678
1.83
8.08
2.0
1.6
—
—
—
0
0
562
4649
1.45
7.91
7.0
6.0
10.98
11.44
umol/l
0.53
532
4410
155
974
1.69
7.79
2.5
2.6
8.33
8.78
umol/l
0.09
125
849
800
7140
1.50
7.17
23.6
18.5
15.32
15.24
%
0.13
792
7025
392
3074
1.44
7.14
3.9
3.4
2.35
2.35
mmol/l
0.05
337
2688
624
5322
1.42
7.07
3.6
3.1
52.24
52.07
u/l
0.01
577
4913
725
6367
1.44
6.89
4.5
4.0
15.11
14.94
pmol/l
0.98
666
5720
329
2512
1.45
6.86
3.6
3.2
0.64
0.48
e6/l
0.23
252
1949
56
266
2.17
6.59
1.5
1.4
308.38
289.59
ug/g
0.30
37
163
351
2737
1.42
6.45
3.8
3.3
36.04
94.48
e6/l
1.51
274
2145
123
765
1.69
6.40
2.3
2.1
357.75
373.37
nmol/l
0.42
114
693
239
1737
1.49
6.36
4.1
4.1
110.18
312.98
ng/l
2.50
196
1421
302
2299
1.44
6.31
2.6
2.7
1676.37
6330.39
umol/l
2.27
268
1980
846
7709
1.50
6.18
5.4
4.8
1.93
2.11
mu/l
0.53
781
6953
203
1438
1.51
6.10
3.1
3.0
1.97
2.01
e6/l
0.02
107
802
350
2750
1.41
6.09
2.0
2.1
184.37
240.23
u/l
0.70
330
2580
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
60
303
2.04
6.05
2.0
2.7
0.29
0.37
u/ml
1.12
29
175
857
7861
1.48
5.75
6.5
6.1
40.45
40.34
mmol/mol
0.12
792
7220
130
850
1.60
5.56
2.3
2.1
0.21
0.21
g/l
0.16
117
796
214
1569
1.46
5.37
1.9
1.9
—
—
—
0
0
210
1539
1.45
5.28
2.8
2.8
1.24
1.10
e6/l
0.14
112
899
336
2680
1.37
5.19
2.9
3.1
33.15
32.54
u/l
0.11
307
2547
971
9215
1.69
4.98
29.8
23.1
246.41
245.60
e9/l
0.14
950
8985
110
710
1.61
4.97
3.6
3.8
88.79
87.72
ng/l
0.04
88
612
971
9218
1.69
4.93
29.8
23.0
4.42
4.44
e12/l
0.53
950
8962
971
9219
1.69
4.91
30.0
23.2
132.63
134.01
g/l
2.04
958
9067
235
1783
1.41
4.85
4.0
3.0
2.46
2.46
mmol/l
0.17
200
1570
970
9215
1.67
4.79
29.9
23.1
39.73
39.73
%
0.01
908
8558
247
1899
1.39
4.71
1.8
1.6
1.23
1.23
mg/l
0.01
193
1464
943
8906
1.56
4.68
13.1
10.7
24.88
25.19
u/l
0.27
913
8563
251
1945
1.38
4.55
3.0
2.6
5.89
5.52
e6/l
0.16
220
1769
149
1051
1.49
4.53
3.1
3.8
246.99
250.41
u/l
0.09
142
996
283
2243
1.36
4.44
1.7
1.6
19.54
20.49
nmol/l
0.49
243
1899
194
1446
1.42
4.41
3.3
3.1
0.81
0.82
mmol/l
0.51
178
1349
162
1168
1.46
4.40
5.5
5.5
1.05
1.03
mmol/l
0.45
144
1071
187
1388
1.42
4.35
1.9
1.9
29.35
29.62
s
0.31
180
1335
118
803
1.53
4.26
7.0
7.0
11.45
10.43
mmol/l
0.68
109
762
73
442
1.70
4.24
1.6
1.9
1.65
1.52
g/l
0.53
63
391
852
7929
1.39
4.21
19.1
14.6
76.30
76.93
ml/min/173m2
0.36
733
6579
151
1092
1.45
4.04
2.7
2.5
1.67
1.83
%
1.36
131
976
121
838
1.50
4.02
6.0
6.2
1.44
1.37
mmol/l
0.20
116
816
9
14
6.47
3.98
1.7
1.3
58.78
48.29
umol/l
—
9
14
530
4637
1.29
3.98
2.9
2.7
—
—
—
0
0
877
8225
1.40
3.93
5.2
4.8
6.01
6.00
mmol/l
0.05
802
7393
151
1099
1.44
3.90
6.0
6.6
5.03
5.09
kpa
0.30
138
1055
72
445
1.66
3.90
2.7
3.1
4.47
4.45
pmol/l
0.04
63
384
151
1100
1.43
3.88
6.0
6.6
12.06
11.91
kpa
0.15
140
1058
10
19
5.30
3.83
1.2
1.7
48.70
92.58
nmol/24h
—
10
19
349
2906
1.30
3.80
2.8
3.0
1682.11
1554.61
ng/l
0.18
310
2498
150
1099
1.42
3.74
6.0
6.6
0.48
1.28
mmol/l
1.28
123
867
184
1397
1.38
3.73
1.3
1.3
30.97
35.35
iu/ml
0.20
51
461
417
3559
1.28
3.73
4.4
3.9
44.26
53.26
ng/l
0.31
287
2614
151
1109
1.42
3.71
1.7
1.8
—
—
—
0
0
280
2273
1.32
3.65
1.6
1.7
1.34
1.37
mmol/l
0.31
227
1893
177
1344
1.38
3.59
1.3
1.2
7.09
13.96
u/ml
0.78
54
471
44
243
1.85
3.53
2.6
1.7
—
—
—
0
0
33
166
2.02
3.47
4.1
3.1
3.63
4.45
e9/l
1.60
33
166
216
1701
1.34
3.46
1.2
1.2
1.06
1.61
u/ml
0.57
41
439
34
173
2.00
3.46
4.2
3.4
56.65
59.26
%
0.57
34
173
58
351
1.69
3.42
4.9
3.2
122.23
4147.05
u/ml
0.79
53
297
234
1874
1.32
3.33
1.9
1.7
1053.07
1198.83
nmol/l
1.79
166
1385
37
198
1.90
3.28
1.3
1.3
—
—
—
0
0
37
198
1.90
3.28
1.3
1.3
—
—
—
0
0
148
1113
1.38
3.18
1.7
1.8
—
—
—
0
0
87
593
1.51
3.16
1.8
1.7
—
—
—
0
0
194
1537
1.32
2.97
1.6
1.5
2.41
2.55
g/l
0.48
116
917
131
979
1.39
2.93
4.4
3.5
—
—
—
0
0
36
203
1.80
2.76
2.2
1.8
—
—
—
0
0
889
8463
1.32
2.75
5.4
5.1
2.70
2.68
mmol/l
0.22
830
7700
213
1729
1.29
2.72
3.6
3.1
0.78
0.80
ug/l
0.12
152
1179
28
146
1.94
2.72
1.3
1.3
—
—
—
0
0
47
293
1.63
2.54
1.3
1.2
—
—
—
0
0
15
62
2.44
2.54
1.3
1.3
—
—
—
0
0
15
62
2.44
2.54
1.3
1.3
—
—
—
0
0
15
63
2.40
2.47
2.0
1.2
—
—
—
0
0
23
116
2.00
2.46
1.7
1.5
—
—
—
0
0
15
64
2.36
2.39
2.0
1.2
—
—
—
0
0
23
118
1.97
2.36
1.7
1.5
—
—
—
0
0
23
118
1.97
2.36
1.7
1.5
—
—
—
0
0
83
1130
0.71
2.33
7.1
7.8
—
—
—
0
0
56
374
1.52
2.29
2.7
2.5
—
—
—
0
0
9
29
3.12
2.22
1.6
1.1
—
—
—
0
0
33
196
1.71
2.17
4.0
2.5
16.50
15.93
%
0.31
21
101
105
803
1.34
2.08
2.8
3.1
275.93
228.26
ng/l
0.47
90
741
22
117
1.90
2.07
1.8
1.5
—
—
—
0
0
15
69
2.19
2.05
1.2
1.1
—
—
—
0
0
832
7933
1.23
2.03
4.1
4.1
1.30
1.28
mmol/l
0.38
753
7132
858
8215
1.24
1.96
4.7
4.5
1.47
1.46
mmol/l
0.28
786
7448
10
39
2.58
1.94
4.3
4.3
—
—
—
0
0
12
52
2.32
1.88
1.3
1.4
—
—
—
0
0
12
52
2.32
1.88
1.3
1.4
—
—
—
0
0
9
35
2.58
1.80
2.4
2.7
40844.44
37545.86
ug/l
—
9
35
9
35
2.58
1.80
2.3
1.3
—
—
—
0
0
464
4235
1.17
1.76
4.1
3.9
0.00
0.00
estimate
0.50
110
887
31
193
1.62
1.76
3.0
3.0
80.32
1968.76
u/ml
0.82
26
181
21
117
1.81
1.75
1.8
1.5
—
—
—
0
0
340
3030
1.18
1.73
5.6
5.2
4.43
2.95
ug/l
0.40
306
2673
22
125
1.78
1.72
1.7
1.9
32.23
32.79
pg
0.22
22
125
21
118
1.79
1.71
1.8
1.5
—
—
—
0
0
76
577
1.34
1.62
4.9
3.6
1.18
1.96
mmol/l
1.00
66
440
38
254
1.51
1.62
2.4
1.8
—
—
—
0
0
31
198
1.58
1.61
1.6
1.4
—
—
—
0
0
276
2431
1.18
1.60
4.4
4.5
23.16
21.28
%
1.00
137
1217
31
199
1.57
1.58
2.1
1.5
—
—
—
0
0
11
50
2.21
1.57
1.0
1.0
—
—
—
0
0
103
821
1.28
1.56
1.6
1.8
1.50
1.51
%
0.04
87
703
68
512
1.35
1.54
1.3
1.3
13.82
49.07
au/ml
—
5
29
859
8283
1.20
1.51
4.8
4.6
4.62
4.58
mmol/l
0.50
791
7581
79
611
1.32
1.50
5.1
3.6
5.11
5.16
kpa
0.17
74
585
135
1118
1.24
1.49
5.2
4.7
32.92
32.70
%
0.09
106
743
33
219
1.52
1.47
1.5
1.2
—
—
—
0
0
11
52
2.13
1.44
1.2
1.1
276.91
244.96
mg/l
0.25
11
46
9
41
2.20
1.37
1.7
1.8
—
—
—
0
0
9
41
2.20
1.37
1.0
1.1
—
—
—
0
0
51
375
1.38
1.36
2.0
1.9
—
—
—
0
0
70
543
1.31
1.33
1.6
1.5
—
—
—
0
0
457
4232
1.14
1.32
5.4
5.2
0.00
0.00
estimate
0.50
107
824
14
76
1.85
1.30
1.1
1.3
—
—
—
0
0
35
245
1.44
1.24
1.5
1.6
—
—
—
0
0
29
196
1.49
1.22
1.2
1.3
—
—
—
0
0
11
56
1.97
1.22
1.3
2.1
—
—
—
0
0
14
78
1.80
1.21
1.3
1.1
—
—
—
0
0
68
534
1.29
1.20
2.9
1.9
—
—
—
0
0
308
2796
1.14
1.18
3.3
3.1
7.14
7.35
mmol/l
0.34
263
2325
14
79
1.78
1.17
2.1
1.6
—
—
—
0
0
5
20
2.51
1.15
1.6
2.6
6.36
7.87
mmol/l
—
5
13
44
327
1.36
1.14
2.8
2.8
—
—
—
0
0
459
4284
1.13
1.13
4.1
3.9
0.00
0.01
estimate
0.80
102
804
8
40
2.01
1.12
1.6
1.9
—
—
—
0
0
8
40
2.01
1.12
1.6
1.9
—
—
—
0
0
12
68
1.77
1.00
2.3
2.1
13.42
13.19
%
0.27
12
68
90
750
1.22
0.99
6.1
3.8
1.23
1.23
mmol/l
0.26
76
650
60
479
1.27
0.97
2.9
1.8
—
—
—
0
0
223
2009
1.14
0.96
1.8
1.7
428.67
17241808.46
pmol/l
1.55
189
1624
28
199
1.42
0.96
3.5
2.2
127.32
128.61
g/l
0.10
22
153
9
51
1.77
0.94
2.0
1.7
—
—
—
0
0
9
51
1.77
0.94
2.0
1.7
—
—
—
0
0
9
52
1.74
0.92
1.1
1.7
—
—
—
0
0
9
52
1.74
0.92
1.1
1.7
—
—
—
0
0
6
28
2.15
0.91
1.8
1.1
—
—
—
0
0
44
341
1.30
0.90
2.2
1.8
—
—
—
0
0
6
29
2.07
0.89
1.0
1.0
—
—
—
0
0
8
42
1.91
0.88
1.1
1.4
1.58
1.60
g/l
—
8
42
100
854
1.19
0.87
3.6
3.4
1.61
2.01
mmol/l
0.54
82
702
308
2847
1.12
0.87
4.0
3.8
7.86
8.74
mg/mmol
0.19
198
1786
8
44
1.82
0.86
1.3
1.1
—
—
—
0
0
28
204
1.38
0.85
1.4
1.4
—
—
—
0
0
16
104
1.55
0.84
2.5
3.5
—
—
—
0
0
14
88
1.60
0.84
1.2
1.1
—
—
—
0
0
33
432
0.76
0.83
5.2
3.7
48.81
49.09
%
0.02
33
426
25
180
1.40
0.82
1.2
1.2
3.71
3.80
mmol/l
0.21
25
166
0
24
0.00
0.79
0.0
1.0
—
9.35
—
0
24
5
24
2.09
0.74
1.6
1.1
—
—
—
0
0
5
24
2.09
0.74
1.6
1.1
—
—
—
0
0
9
54
1.67
0.74
1.4
1.4
1.09
1.02
g/l
—
9
54
7
39
1.80
0.72
1.4
1.2
212.51
147.40
pmol/l
—
7
39
5
26
1.93
0.70
2.4
1.8
—
—
—
0
0
129
1148
1.14
0.69
1.4
1.4
—
—
—
0
0
9
146
0.61
0.69
1.7
1.5
—
—
—
0
0
9
146
0.61
0.69
1.7
1.5
—
—
—
0
0
22
161
1.37
0.68
2.0
1.7
—
—
—
0
0
23
170
1.36
0.67
1.3
1.3
192.91
234.27
miu/ml
—
10
71
32
249
1.29
0.67
1.8
1.8
—
—
—
0
0
15
102
1.48
0.67
2.0
1.7
—
—
—
0
0
17
119
1.44
0.67
1.5
1.3
2743.67
1558.69
e6/l
0.38
12
83
39
313
1.25
0.65
4.0
3.8
42.97
47.74
mg/l
0.14
30
259
39
313
1.25
0.65
4.0
3.7
93.52
72.75
mg/l
0.21
30
259
98
861
1.15
0.64
3.7
3.4
5.74
5.83
kpa
0.42
92
838
287
2689
1.09
0.62
3.5
3.2
1145.77
315.73
mg/l
1.00
188
1721
28
217
1.30
0.62
3.5
3.0
2.16
1.73
mg/l
0.86
28
197
27
209
1.30
0.60
1.2
1.2
11.32
9.81
u/ml
—
5
34
15
105
1.43
0.60
1.3
1.4
—
—
—
0
0
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
33
263
1.26
0.60
1.4
1.6
—
—
—
0
0
21
157
1.34
0.59
1.4
1.2
26.52
28.18
u/ml
—
5
13
8
53
1.51
0.58
1.6
1.7
—
—
—
0
0
8
53
1.51
0.58
1.6
1.7
—
—
—
0
0
6
36
1.67
0.56
1.0
1.2
5.42
6.57
mmol/l
—
6
36
119
1071
1.12
0.56
1.5
1.4
—
—
—
0
0
46
384
1.21
0.56
4.7
4.8
1.48
1.58
%
0.44
41
364
14
99
1.42
0.54
3.1
2.6
—
—
—
0
0
15
204
0.73
0.53
1.4
1.4
—
—
—
0
0
9
63
1.43
0.52
2.0
1.6
—
—
—
0
0
6
40
1.50
0.51
1.0
1.2
—
—
—
0
0
6
41
1.47
0.50
3.2
1.2
—
—
—
0
0
42
353
1.20
0.49
1.1
1.0
—
—
—
0
0
12
84
1.43
0.49
1.2
1.1
—
—
—
0
0
37
308
1.21
0.48
4.1
3.7
—
1.88
—
0
27
7
46
1.52
0.48
2.0
1.9
0.26
0.23
e9/l
—
7
41
13
93
1.40
0.48
1.6
1.4
163.54
307.52
pmol/l
2.57
13
82
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
47
1.49
0.47
1.4
1.2
—
—
—
0
0
7
48
1.46
0.47
2.0
1.8
505.86
637.80
e6/l
—
7
41
62
544
1.15
0.45
2.2
2.1
12.59
12.67
nmol/l
0.02
57
481
16
121
1.33
0.44
2.5
1.9
1050.17
1234.23
u/l
—
6
42
342
3272
1.07
0.43
4.5
4.1
—
—
—
0
0
31
257
1.21
0.43
1.3
1.2
—
—
—
0
0
5
31
1.62
0.43
1.2
3.6
—
707.63
—
0
8
31
258
1.21
0.42
1.3
1.2
—
—
—
0
0
21
167
1.26
0.42
2.4
1.4
1.24
0.88
nmol/l
0.85
16
138
0
15
0.00
0.41
0.0
1.1
—
28.63
—
0
10
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
26
213
1.23
0.41
1.5
1.4
—
—
—
0
0
8
59
1.36
0.41
1.4
1.1
—
—
—
0
0
8
59
1.36
0.41
1.4
1.1
—
—
—
0
0
8
59
1.36
0.41
1.4
1.1
—
—
—
0
0
5
34
1.47
0.40
1.4
1.8
4.12
7.26
nmol/l
—
5
26
5
35
1.43
0.39
1.8
1.3
3.09
3.40
ug/l
—
5
27
9
66
1.37
0.38
1.4
1.3
13.11
13.57
u/l
—
9
61
61
544
1.13
0.37
2.1
1.7
—
—
—
0
0
56
497
1.13
0.37
1.3
1.2
109.22
135.59
iu/ml
0.24
18
205
248
2362
1.06
0.36
4.9
4.2
0.00
0.01
estimate
0.88
98
799
21
256
0.82
0.36
1.7
1.6
0.49
24.60
iu/ml
—
5
49
9
71
1.27
0.36
1.0
1.1
—
—
—
0
0
6
42
1.43
0.35
1.2
1.0
—
—
—
0
0
23
190
1.21
0.35
1.3
1.3
—
—
—
0
0
178
1882
0.93
0.34
4.0
4.3
1.02
1.02
kg/l
0.12
27
262
6
45
1.33
0.33
1.0
1.4
—
—
—
0
0
11
83
1.33
0.32
1.2
2.3
—
—
—
0
0
23
193
1.20
0.31
1.1
1.1
—
—
—
0
0
7
53
1.32
0.31
1.4
1.4
—
—
—
0
0
23
194
1.19
0.29
1.1
1.1
—
5.49
—
0
21
7
56
1.25
0.29
1.3
1.2
—
—
—
0
0
16
131
1.22
0.27
2.8
1.6
—
—
—
0
0
9
72
1.25
0.25
1.4
1.2
14.22
11.11
u/l
—
9
65
13
105
1.24
0.24
1.5
1.3
15572.86
88707.30
e6/l
—
7
61
9
76
1.19
0.24
1.3
1.6
—
—
—
0
0
14
115
1.22
0.23
1.6
1.6
61.11
59.51
%
—
9
76
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
88
828
1.07
0.21
2.2
2.6
7.48
6.91
ug/l
0.14
75
723
21
182
1.16
0.21
1.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
6.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
6
48
1.25
0.20
1.2
1.2
—
—
—
0
0
12
144
0.83
0.20
1.2
1.1
—
—
—
0
0
6
50
1.20
0.19
1.0
1.2
—
—
—
0
0
6
52
1.15
0.19
2.5
2.4
—
—
—
0
0
7
58
1.21
0.18
1.4
1.1
—
—
—
0
0
7
58
1.21
0.18
1.4
1.1
—
—
—
0
0
66
701
0.94
0.17
3.6
2.8
59.06
62.83
ml/min/173m2
0.35
33
298
15
129
1.16
0.17
2.0
1.5
—
—
—
0
0
10
120
0.83
0.16
1.1
1.1
—
7.94
—
0
5
8
70
1.14
0.16
1.1
1.1
—
70.43
—
0
7
6
77
0.78
0.15
2.2
1.6
—
—
—
0
0
29
264
1.10
0.15
1.4
1.9
—
—
—
0
0
43
401
1.07
0.14
2.0
1.9
0.61
2.01
ug/l
1.17
37
352
11
93
1.18
0.14
1.3
1.6
—
—
—
0
0
21
233
0.90
0.14
3.4
2.3
89.25
79.38
ug/min
0.06
13
144
12
138
0.87
0.13
1.8
1.5
—
—
—
0
0
40
374
1.07
0.13
1.3
1.3
—
—
—
0
0
58
607
0.95
0.11
5.6
6.2
25.38
24.53
mmol/l
1.16
53
582
14
125
1.12
0.10
1.1
1.1
—
—
—
0
0
17
154
1.11
0.10
1.5
1.5
—
—
—
0
0
5
45
1.11
0.10
1.6
1.1
—
—
—
0
0
75
723
1.04
0.09
3.4
2.7
5.01
4.51
kpa
1.12
70
699
7
67
1.04
0.08
3.0
1.5
—
—
—
0
0
8
74
1.08
0.07
2.4
2.2
—
—
—
0
0
8
78
1.03
0.07
1.8
1.5
—
—
—
0
0
9
87
1.03
0.07
3.1
1.8
—
—
—
0
0
8
94
0.85
0.06
1.9
1.6
—
—
—
0
0
9
104
0.86
0.06
1.1
1.0
—
—
—
0
0
10
90
1.11
0.05
1.3
1.4
—
—
—
0
0
10
90
1.11
0.05
1.3
1.4
—
—
—
0
0
10
90
1.11
0.05
1.3
1.4
—
—
—
0
0
10
90
1.11
0.05
1.3
1.4
—
—
—
0
0
13
140
0.93
0.04
1.2
1.2
319.29
269.81
u/ml
—
7
73
24
229
1.05
0.04
1.9
1.7
22068.21
13337.05
e6/l
0.21
14
165
20
191
1.05
0.03
2.4
1.6
4.41
4.67
iu/l
—
7
55
22
211
1.04
0.03
2.0
1.6
—
—
—
0
0
12
112
1.07
0.02
1.2
1.1
—
—
—
0
0
11
117
0.94
0.02
6.3
5.8
9.43
12.46
mg/l
1.34
11
106
14
147
0.95
0.01
1.1
1.2
—
—
—
0
0
23
223
1.03
0.01
1.9
1.6
—
—
—
0
0
12
126
0.95
0.01
1.8
1.5
—
—
—
0
0
10
95
1.05
0.00
2.9
1.8
—
—
—
0
0
25
246
1.02
0.00
1.5
1.8
3.84
3.14
mg/l
0.24
19
192
16
160
1.00
0.00
2.4
2.0
71.60
59.51
%
2.21
16
160
11
107
1.03
0.00
1.3
1.5
—
—
—
0
0
12
125
0.96
0.00
2.2
2.5
25.40
28.75
mg/l
—
5
31
12
123
0.97
0.00
1.8
1.5
—
—
—
0
0
15
155
0.97
0.00
1.6
1.5
—
—
—
0
0
11
110
1.00
0.00
1.1
1.1
—
—
—
0
0
27
265
1.02
0.00
1.6
1.4
—
—
—
0
0
12
117
1.03
0.00
1.4
1.2
2.67
7.71
u/ml
—
6
49
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
6
69
0.87
-0.00
1.0
1.0
—
—
—
0
0
6
60
1.00
-0.00
1.3
1.3
—
—
—
0
0
8
88
0.91
-0.00
1.6
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
4.2
—
—
—
0
0
8
88
0.91
-0.00
1.6
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
8
88
0.91
-0.00
1.6
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
8
85
0.94
-0.00
1.1
1.2
—
—
—
0
0
7
69
1.01
-0.00
1.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_ANUS_ANAL_CANAL and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_ANUS_ANAL_CANAL | 1.11 [0.99, 1.24] | 0.066 |
| Birth year | 0.998 [0.99, 1.01] | 0.643 |
During the follow-up period (1.1.1998 — 31.12.2019), 811 out of 3244 females with CD2_BENIGN_ANUS_ANAL_CANAL died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_ANUS_ANAL_CANAL | 1.233 [1.1, 1.39] | < 0.001 |
| Birth year | 0.991 [0.98, 1.0] | 0.046 |
During the follow-up period (1.1.1998 — 31.12.2019), 997 out of 2848 males with CD2_BENIGN_ANUS_ANAL_CANAL died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_ANUS_ANAL_CANAL.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.12% | 0.274% |
| 5 | 0.735% | 1.418% |
| 10 | 1.683% | 3.814% |
| 15 | 3.423% | 7.36% |
| 20 | 6.062% | 12.725% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_ANUS_ANAL_CANAL – Benign neoplasm: Anus and anal canal
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data